Management of Pulmonary Arterial Hypertension with Sitaxentan Sodium
Pulmonary arterial hypertension (PAH) is a chronic and progressive disease with a poor prognosis if left untreated. Pathophysiological alterations in this disease lead to vasoconstriction, endothelial and smooth muscle cell proliferation, and in situ thrombosis. Endothelin-1 (one of the most potent...
Saved in:
Published in | Clinical Medicine Insights: Therapeutics Vol. 2011; no. 3; pp. 31 - 38 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article Book Review |
Language | English |
Published |
London, England
Libertas Academica
01.01.2011
SAGE Publishing SAGE Publications Sage Publications Ltd |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!